Related Experiment Video
Updated: Mar 9, 2026

Hydra, a Computer-Based Platform for Aiding Clinicians in Cardiovascular Analysis and Diagnosis
Published on: September 26, 2018
[Practicality of cardiovascular risk functions]
Jaume Marrugat1, Roberto Elosua2, Gloria Icaza3
1Grupo de Epidemiología y Genética Cardiovascular, Instituto Hospital del Mar de Investigaciones Médicas, Barcelona, Cataluña, España. Address: Instituto Hospital del Mar de Investigaciones Médicas, Doctor Aiguader 88, Barcelona, Cataluña, España.
Insights
Improving cardiovascular disease prevention requires better risk assessment. Current risk functions identify high-risk individuals for coronary artery disease, guiding targeted interventions and enhancing patient motivation for lifestyle changes.
Area of Science:
- Cardiology
- Preventive Medicine
- Health Informatics
Background:
- Cardiovascular disease prevention strategies need enhancement due to slow incidence reduction.
- Existing risk functions use classical factors (age, sex, smoking, diabetes, blood pressure, lipids) for population screening, primarily for coronary artery disease.
- These functions are crucial for primary prevention clinical guidelines, stratifying patients to optimize therapeutic efforts.
Purpose of the Study:
- To refine cardiovascular disease prevention strategies by improving risk assessment.
- To highlight the importance of accurate coronary artery disease risk stratification for targeted interventions.
- To explore methods for enhancing patient motivation in adhering to preventive measures.
Main Methods:
- Development of risk functions based on classical cardiovascular risk factors in long-term cohorts (>10 years).
- Analysis of patient risk strata to identify optimal groups for intervention (high-risk).
- Evaluation of communication strategies (relative risk, vascular age) to improve patient compliance.
Main Results:
- Classical risk functions are reasonably precise for coronary artery disease screening.
- Approximately 20% of adults aged 35-74 have intermediate risk, necessitating reclassification.
- Intermediate-risk individuals account for 35% of coronary artery disease events.
- Biomarkers are under investigation to improve risk function precision.
Conclusions:
- Current risk functions are valuable for primary prevention but require refinement.
- Accurate risk communication can motivate patients towards lifestyle and drug modifications.
- Integrating automated risk calculation into health systems can support preventive care providers.
Abstract:
Cardiovascular diseases prevention strategies require refinement because their incidence decreases very slowly. Risk functions were developed by including classical cardiovascular risk factors (age, sex, smoking, diabetes, blood pressure, and basic lipid profile) in cohorts followed more than 10 years. They are reasonably precise for population screening of, principally, coronary artery disease risk, required in all cardiovascular primary prevention clinical guidelines. Coronary artery disease risk functions classify patients in risk strata to concentrate the maximum therapeutic and life style effort in the highest risk groups, in which the number needed to treat and cost-effectiveness are optimal. By communicating the relative risk and vascular age to patients, increased motivation to comply with the proposed drug and life-style modifications can be achieved. Approximately 20% of the population 35 to 74 years old has an intermediate risk that requires reclassification into high or low risk because they concentrate 35% of population coronary artery disease events. Several biomarkers (biochemical, genetic or imaging) are being tested to improve coronary artery disease risk functions precision. Computerized systems of health facilities should incorporate, automated risk calculation in order to support the preventive task of health care providers.
More Related Videos
Related Concept Videos
Assessment of the Cardiovascular System I: Subjective Data
Initial Enquiry
Ask the patient about their primary concern and thoroughly explore all reported symptoms.
Medical History
Investigate past illnesses affecting the cardiovascular system, such as angina, anemia, rheumatic fever, congenital heart disease, stroke, thrombophlebitis, dysrhythmias, varicosities
Inquire about symptoms...
Imaging Studies for Cardiovascular System VI: Calcium -Scoring CT
Pre-Procedural Guidelines for Assessing Blood Pressure
Blood Studies for Cardiovascular System I: Cardiac Biomarkers
The essential diagnostic tools for detecting myocardial necrosis and monitoring individuals suspected of having acute coronary syndrome (ACS) include:
Troponins
Troponins, particularly cardiac troponins I and T, are the most precise and sensitive markers of myocardial injury. They are detectable within 4-6 hours of myocardial injury and remain...
Types of Biopharmaceutical Studies: Controlled and Non-Controlled Approaches
Non-controlled studies, commonly employed for initial exploration, lack a control group, rendering them susceptible to biases and external influences. In contrast,...
Assessment of the Cardiovascular System III: Palpation
Jugular Venous Pressure (JVP) Measurement
Position the patient at a thirty- to forty-five-degree angle or in a semi-fowler's position. Look for the highest point of pulsation in the internal jugular vein and measure the vertical distance to the angle of Loius or sternal angle. A normal JVP is 3-4 cm above...

